Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | L344Q |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 L344Q lies within the tetramerization domain of the Tp53 protein (PMID: 20978130). L344Q results in decreased Tp53 oligomer formation and transcriptional activity in yeast (PMID: 16007150), and the corresponding canine variant (L332Q) demonstrates impaired tetramerization, but not dimerization (PMID: 29750295), and therefore, is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon10 TP53 L344Q TP53 mutant TP53 inact mut TP53 L344Q |
Transcript | NM_000546.6 |
gDNA | chr17:g.7670678A>T |
cDNA | c.1031T>A |
Protein | p.L344Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001276761.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001276761 | chr17:g.7669642_7669643delGAinsTT | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126118 | chr17:g.7669642_7669643delGAinsTT | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001276760.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126118.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001276760 | chr17:g.7669642_7669643delGAinsTT | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.7669642_7669643delTCinsAA | c.1031_1032delTCinsAA | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7670678A>T | c.1031T>A | p.L344Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|